Lect Final 86% Flashcards
(37 cards)
Infant Sample collection
- Must minimize the amount of sample drawn, due to small blood volume in infants
“Well” infants experience
– Immune thrombocytopenia, vitamin K deficiency,
hemophilia, bleeding from a localized vascular lesion
sick infants
– Prematurity, perinatal infection, respiratory distress
syndrome, metabolic derangements, birth asphyxia
▪ DIC, liver failure, isolated platelet consumption defect
Identifying aPL Antibodies
- Prolongation of a PL-dependent coagulation test (e.g.,
APTT, dRVVT, KCT) - Evidence of inhibitor activity (lack of correction by a 1:1
mix with normal plasma) - Confirmation that inhibitory effect blocks PL-dependent
coagulation (i.e., neutralization of inhibitor effect by
addition of excess PLs or changing PL source) - Absence of specific inhibitor against a coagulation factor
Antiphospholipid Antibody Syndrome
(APLS
-Not clearly understood
-presents as VTE (DVT, PE), arterial thromboses (stroke, TIA, MI)
- recurrent miscarriages
- Antiphospholipid antibodies
▪ Lupus anticoagulant (LA)
▪ Anticardiolipin antibodies (aCL)
▪ Several subgroups—antibodies to PLs and PL binding
proteins
negatively charged surface
repels platelet and hemostatic proteins
heparan sulfate(HS)
inhibits fibrin formation - cofactor for antithrombin
thrombomodulin(TM)
binds thrombin and enhances activation of protein C
endothelial protein C receptor
binds protein C and facilitates PC activation
Tissue Factor pathway inhibitor TFPI
Binds TF/FVIIA/FXa complex
inhibits extrinsic pathway of coagulation
Postacyclin PGI2
promotes vasodilation, inhibits platelet activation
Tissue plasminogen activator tPA
activates fibrinolysis system
Annexin A2 -tPa receptor A2
binds tPA and plasminogen, activates finbrinolysis
Urinary type plasminogen activator
binds uPAR and plasminogen, activates fifrinolysis
Nitric oxide NO
promotes vasodilation, inhibits platelet recruitment and accumulation
ADPase CD39
degrades ATP and ADP to AMP anf adenosine
Endothelin ET
promotes vasoconstriction
vWF
carries FVIII in plasma, facilitates platelet adhesion
tissue factor TF
initiates fibrin formation, activates FVII
plasminogen activator inhibitor PAI-1
inhibits activation of fibrinolysis
what activates fibrinolysis
tPA, A2, uPA, uPAR
what is the difference btwn resting endothelium and activated
answer in book
what are the 2 membrane systems
open canalicular
dense tubular